These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 15746665

  • 1. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA.
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [Abstract] [Full Text] [Related]

  • 2. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
    Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H.
    Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K, Maeshima Y, Kobayashi K, Matsuura E, Sugiyama H, Yamasaki Y, Masuyama H, Hiramatsu Y, Makino H.
    Nephron Clin Pract; 2007 Jan; 106(1):c43-50. PubMed ID: 17409768
    [Abstract] [Full Text] [Related]

  • 4. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia.
    Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, Fiedler GM, Luthe H, Denk B, Smitz J.
    Clin Biochem; 2010 Jun; 43(9):768-70. PubMed ID: 20206155
    [Abstract] [Full Text] [Related]

  • 5. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [Abstract] [Full Text] [Related]

  • 6. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G, Markovic N.
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [Abstract] [Full Text] [Related]

  • 7. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
    Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT.
    Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927
    [Abstract] [Full Text] [Related]

  • 8. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY.
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [Abstract] [Full Text] [Related]

  • 9. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH, Liu L, Zhan Y, Peng W.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [Abstract] [Full Text] [Related]

  • 10. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.
    Krysiak O, Bretschneider A, Zhong E, Webb J, Hopp H, Verlohren S, Fuhr N, Lanowska M, Nonnenmacher A, Vetter R, Jankowski J, Paul M, Schönfelder G.
    Circ Res; 2005 Dec 09; 97(12):1253-61. PubMed ID: 16269656
    [Abstract] [Full Text] [Related]

  • 11. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH, Liu L, Zhan Y, Peng W.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul 09; 41(7):433-5. PubMed ID: 17083803
    [Abstract] [Full Text] [Related]

  • 12. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS, Baumbusch MA, Dulay AT, Lee S, Wehrum M, Zhao G, Bahtiyar MO, Pettker CM, Ali UA, Funai EF, Buhimschi IA.
    BJOG; 2010 Feb 09; 117(3):321-30. PubMed ID: 19943826
    [Abstract] [Full Text] [Related]

  • 13. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
    Sun SG, Shen N, Zheng YH, Shang T.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul 09; 41(7):440-4. PubMed ID: 17083805
    [Abstract] [Full Text] [Related]

  • 14. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia.
    Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y.
    BJOG; 2010 Feb 09; 117(3):314-20. PubMed ID: 20015306
    [Abstract] [Full Text] [Related]

  • 15. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
    Hamar BD, Buhimschi IA, Sfakianaki AK, Pettker CM, Magloire LK, Funai EF, Copel JA, Buhimschi CS.
    Am J Obstet Gynecol; 2006 Dec 09; 195(6):1636-45. PubMed ID: 16959203
    [Abstract] [Full Text] [Related]

  • 16. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
    Chen Q, Zhao Y, Zou L, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar 09; 42(3):161-4. PubMed ID: 17537299
    [Abstract] [Full Text] [Related]

  • 17. Fractional excretion of angiogenic factors in women with severe preeclampsia.
    Buhimschi CS, Magloire L, Funai E, Norwitz ER, Kuczynski E, Martin R, Richman S, Guller S, Lockwood CJ, Buhimschi IA.
    Obstet Gynecol; 2006 May 09; 107(5):1103-13. PubMed ID: 16648417
    [Abstract] [Full Text] [Related]

  • 18. Altered hemodynamics and hyperuricemia accompany an elevated sFlt-1/PlGF ratio before the onset of early severe preeclampsia.
    Doherty A, Carvalho JC, Drewlo S, El-Khuffash A, Downey K, Dodds M, Kingdom J.
    J Obstet Gynaecol Can; 2014 Aug 09; 36(8):692-700. PubMed ID: 25222164
    [Abstract] [Full Text] [Related]

  • 19. Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.
    Wang Y, Zhao S, Loyd S, Groome LJ.
    Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1084-9. PubMed ID: 22301621
    [Abstract] [Full Text] [Related]

  • 20. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.
    Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM.
    Am J Reprod Immunol; 2015 May 01; 73(5):437-44. PubMed ID: 25521546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.